Quidel (NASDAQ: QDEL) is a testing company that's been experiencing tremendous sales growth over the past year, largely because of the popularity of its COVID-19 tests amid the pandemic. But testing volumes are down and there's an uncertain path ahead, so I decided to sell my holdings. There's just too much risk with the stock right now.
Shares are down 17% year to date (while the S&P 500 is up 18%), and it's possible that Quidel's stock could fall even lower before the year is over. Here are the three main reasons I decided to give up on the stock.
Image source: Getty Images.
Source Fool.com